Stockreport

AIM ImmunoTech to Participate in Virtual Investor CEO Connect Segment

AIM ImmunoTech Inc.  (AIM) 
PDF OCALA, Fla., Sept. 27, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, Chief Executiv [Read more]